10 withdrawn. 10 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 10 | Withdrawn 10 |
Follow Blood Coagulation Disorders: new trials by email Literature Review of Blood Coagulation Disorders trials Research Report on Blood Coagulation Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies Eloctate, Adynovate, Emicizumab - Hemophilia A, Factor VIII | Phase 4 | Withdrawn | University of Texas Southwestern Medical Center | 2021-04-15 | 2026-04-07 | |
| Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months Plasma - Blood Coagulation Disorders | Phase 4 | Withdrawn | University of Chicago | 2017-10-01 | 2018-10-24 | |
| Atenativ Effect on Uterine Blood Flow and Preeclampsia Atenativ - Antithrombin III Deficiency | Phase 4 | Withdrawn | Vastra Gotaland Region | 2016-01-01 | 2017-09-26 | |
| Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP) Dexamethasone (4 cycles), Dexamethasone (1 cycle) - Immune Thrombocytopenia | Phase 4 | Withdrawn | Shandong University | 2015-11-01 | 2016-04-20 | |
| Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease plasma-derived FVIII/VWF concentrate - Von Willebrand Disease | Phase 4 | Withdrawn | Grifols Therapeutics LLC | 2013-12-01 | 2026-05-22 | |
| Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura Octaplas infusion and placebo (group 1), Octaplas infusion and placebo (group 2) - Purpura, Thrombotic Thrombocytopenic | Phase 4 | Withdrawn | St. Olavs Hospital | 2012-09-01 | 2012-12-21 | |
| Study Using Plasma for Patients Requiring Emergency Surgery Human Plasma - Hemorrhagic Shock, Blood Coagulation Disorders | Phase 4 | Withdrawn | Ottawa Hospital Research Institute | 2012-03-01 | 2023-05-08 | |
| PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care Warfarin Dosing - Blood Coagulation Disorders | Phase 4 | Withdrawn | University of Florida | 2006-07-01 | 2012-02-16 | |
| Study Evaluating Inhibitor Specificity in Hemophilia A single blood draw - Hemophilia A | Phase 4 | Withdrawn | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-11-01 | 2012-06-28 | |
| Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A ReFacto, Advante - Hemophilia A | Phase 4 | Withdrawn | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-04-01 | 2018-09-25 |
Hemophilia A (3) · Antithrombin III Deficiency (1) · Hemorrhage (1) · Hemostatic Disorders (1) · Pre-Eclampsia (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Purpura, Thrombotic Thrombocytopenic (1) · Shock, Hemorrhagic (1) · Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, Type 2 (1) · Wounds and Injuries (1) · von Willebrand Diseases (1)
Hematologic Diseases (10) · Hemic and Lymphatic Diseases (10) · Hemorrhagic Disorders (6) · Blood Coagulation Disorders, Inherited (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Coagulation Protein Disorders (4) · Blood Platelet Disorders (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Cytopenia (2) · Hemorrhage (2) · Purpura (2) · Purpura, Thrombocytopenic (2)
Antithrombin III (1) · BAX 855 (1) · Blood Specimen Collection (1) · Dexamethasone (1) · Solutions (1) · Solvents (1) · emicizumab (1) · factor VIII-Fc fusion protein (1) · recombinant factor VIII SQ (1)
Wyeth is now a wholly owned subsidiary of Pfizer (2) · Grifols Therapeutics LLC (1) · Ottawa Hospital Research Institute (1) · Shandong University (1) · St. Olavs Hospital (1) · University of Chicago (1) · University of Florida (1) · University of Texas Southwestern Medical Center (1) · Vastra Gotaland Region (1)
United States (5) · Belgium (2) · France (2) · Germany (2) · Italy (2) · Spain (2) · United Kingdom (2) · Canada (1) · China (1) · Netherlands (1) · New Zealand (1) · Sweden (1)
Anne S von Krogh, MD (1) · David T Neilipovitz, MD (1) · Jessica Garcia, MD (1) · Julie A Johnson, Pharm.D. (1) · Margareta Hellgren, MD,PhD,prof (1) · Ming Hou, MD, PhD (1)
PMID 11057854, PMID 14719181, PMID 15500369, PMID 17636190, PMID 18226126, PMID 2329037, PMID 6484893, PMID 6618278, PMID 6872275